Heidelberg Pharma Provides Update on Phase I/IIa Clinical Trial with Lead Candidate HDP-101

Ascendis Pharma Launches SKYTROFA® in Germany for the Treatment of Growth Hormone Deficiency

Affimed Receives FDA Fast Track Designation for AFM13 in Combination with AlloNK®

Ariadne.ai - Looking for beta testers for new spatial biology software-as-a-service (SaaS) plattform

BioLabs Heidelberg: We are growing!

Heidelberg Pharma’s Partner Takeda Reached Development Milestone

How can big Data in Medical Research eliminate Health Disparities?

Harrow Acquires U.S. and Canadian Commercial Rights to VEVYE® from Novaliq

EMBL and ZEISS enter long-term strategic partnership

YUMAB and InSCREENeX in joint funding Project

Survey: Bioinformatics training needs

New Center to advance innovative approaches for Cell and Gene Therapy

Skin rejuvenation for cancer prevention: DKFZ and Beiersdorf establish Joint Innovation Lab

BioMed X Institute Starts Its First Research Project with Sanofi on Artificial Intelligence

Helmholtz Institute for Translational Angiocardioscience founded

Novaliq Announces FDA Approval of VEVYE™ (Cyclosporine Ophthalmic Solution) 0.1%

Apogenix’ new CD40 agonist HERA-CD40L significantly reduces tumor growth in prostate cancer model

Singleron and Sciomics – Collaborating in the pursuit of Precision Medicine

Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO for the Treatment of Dry Eye Disease

First company in the world to offer preclinical drug tests for children with cancer